Haleon plc (HLN) - Long-Term Debt to Capital

Corporate emblem and logo of haleon.com (HLN)

Haleon plc, a leader in the over-the-counter and hygiene segment, is implementing eco-friendly packaging made from recyclable plastic and optimizing water consumption. The business relies on partnerships with digital health services and the targeted acquisition of niche brands. The share price history on GURU.Markets, where the individual long-term debt metric is 0.39, is supplemented by data on a stable workforce and the hiring of e-commerce experts.

Haleon Group (HLN) - Long-Term Debt to Equity from 04/28/2023 to 10/31/2026
Core merchandise of haleon.com

To minimize debt risks, it is essential for investors to monitor 0.39, which reflects the share of loans with a maturity of over one year within the equity structure. Haleon plc (HLN) transition to renewable energy and sustainable packaging requires stable financing; therefore, analyzing the ratio of long-term loans to equity confirms the company's ability to sustain capital-intensive modernization without threatening the business's financial stability.

Competing companies

KVUE: Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital VRNA|Long-Term Debt to Capital Jyong Bio (MENS)|Long-Term Debt to Equity Ligand Pharmaceuticals LGND|Long-Term Debt to Capital Coefficient AMRX|PRGO - Long-Term Debt to Equity|Alvotech S.A. (ALVO) - Long-Term Debt to Equity Ratio|LQDA: Long-Term Debt to Capital|Galapagos Corp (GLPG) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio ANIP|MNKD: Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX - Long-Term Liabilities to Capital|ARS Pharma - Long-Term Debt to Equity Ratio|Long-Term Loans to Capital Ratio TBPH (Theravance Corp)|Aquestive Therapeutics - Long-Term Debt to Capital|Long-Term Debt to Capital Coefficient SCPH (scPharmaceuticals Inc.)|TECX: Long-Term Debt to Capital|Long-Term Liabilities to Capital Tonix Pharma (TNXP)|Long-Term Debt to Equity SXT Pharmaceuticals|EPRX: Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital BHST|EXOZ (invizyne.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital ORMP (Oramed Pharmaceuticals Inc.)|Long-Term Debt to Capital Entera Bio Ltd ENTX|HYFT - Long-Term Debt to Equity|ABVC: Long-Term Debt to Equity|CPIX: Long-Term Debt to Capital|Long-Term Liabilities to Capital quantumbiopharma.com (QNTM)|Long-Term Debt to Equity FibroGen|Long-Term Liabilities to Capital Telomir Pharmaceuticals Inc TELO|Long-Term Debt to Equity Rani Therapeutics (RANI)|synergychc.com - Long-Term Debt to Capital Ratio|Rallybio - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient LEXX|PULM - Long-Term Debt to Equity|Long-Term Liabilities to Equity PTHL|aptorumgroup.com (APM) - Long-Term Debt to Equity|LYRA (Lyra Therapeutics Inc) - Long-Term Debt to Equity|IBO (Impact BioMedical Inc) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio TNF Pharma (TNFA)|Long-Term Debt to Capital YCBD|PRFX (PainReform Ltd) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Altamira Therapeutics Ltd. CYTO|Lipella Pharma - Long-Term Debt to Equity|OPTN - Long-Term Debt to Equity|PIRS (pieris.com) - Long-Term Debt to Capital Ratio|Procaps (PROC) - Long-Term Debt to Equity|Long-Term Liabilities to Equity PTPI (Petros Pharmaceuticals Inc)|QLI (Qilian International Holding Group Limited) - Long-Term Debt to Capital|SLRN: Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital TFFP